Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Ipilimumab × Clear all

Phase

Phase 2 3 Phase 1 3 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 15 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 6 Stomach Neoplasms 3 Mesothelioma 3 Kidney Neoplasms 3 Skin Neoplasms 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Diabetes Mellitus, Insulin-Dependent, 12 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Various Advanced Cancer 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Colonic Neoplasms 1

Interventions

Fluorouracil 57 Leucovorin 56 Oxaliplatin 38 Irinotecan 25 Folfox protocol 19 Capecitabine 18 Bevacizumab 17 Cetuximab 12 Chemotherapy, Adjuvant 11 Aspirin 6 Laparoscopy 5 Celecoxib 5 XELOX 4 dehydroftorafur 3 Panitumumab 3 Observation 3 Levamisole 3 Floxuridine 3 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Tegafur 2 Standard of Care 2 Octreotide 2 Occult Blood 2 Nivolumab 2 Neoadjuvant Therapy 2 Mitomycin 2 Immunoglobulin G 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡